Changes in A1C Versus GMI Across Glycemic Categories in Clinical Trials of Type 1 Diabetes
Change in GMI is influenced by the baseline A1C of the participants and it underestimates the true change in A1C. Use of GMI as an endpoint in clinical trials may not reliably capture efficacy of an intervention in T1D trials or real-world studies.
Authors
- Sebastián E Abad (ORCID: https://orcid.org/0000-0002-4515-9539)
- Eslam Montaser (ORCID: https://orcid.org/0000-0002-3138-1964)
- Viral N. Shah (ORCID: https://orcid.org/0000-0002-3827-7107)
Institutions
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1210/clinem/dgaf211
- Citations
- 4
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 5.18